logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
G

Germana Tognon

obstetrics and gynecology
H指数:25
被引数:3,460

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Decoding BRCA1 and BRCA2 mutations in high-grade serous ovarian cancer: impact of location and type of mutation on prognosis and PARP inhibitor treatment

解码高级别浆液性卵巢癌中的BRCA1和BRCA2突变：突变位置和类型对预后及PARP抑制剂治疗的影响

International Journal of Gynecological Cancer
IF4.7
2026-04-030
PRE
Marina Momi; Elisa Salviato; Antonella Ravaggi; Cinzia Mazza; Germana Tognon; Cosetta Bergamaschi; Laura Zanotti; Elisa Gozzini; Valentina Zizioli; Franco Odicino; Eliana Bignotti
Rational adjustment of dose to reduce adverse reactions (RADAR) in patients with platinum-sensitive recurrent ovarian cancer: Results from the phase II NEWTON trial (ENGOT-ov49)

铂敏感复发性卵巢癌患者中基于合理剂量调整以减少不良反应（RADAR）的结果：来自II期NEWTON试验（ENGOT-ov49）的数据

European Journal of Cancer
IF7.1
2026-03-270
PRE
Nicoletta Colombo; Gabriella Parma; Giulia Tasca; Michele Pio Di Palma; Germana Tognon; Andrea Alberto Lissoni; Roldano Fossati; Luciano Carlucci; Massimo Zucchetti; Cristina Matteo; Annamaria Ferrero; Alessandra Bologna; Mara Mantiero; Pauline Wimberger; Dionyssios Katsaros; Federica Tomao; Francesca Galli; Mariateresa Lapresa; Valentina Guarneri; Silvia Ficarelli
Letrozole for hormone receptor-positive low-grade ovarian cancer: Preliminary toxicity results of a phase III trial

来曲唑用于激素受体阳性低级别卵巢癌：一项III期试验的初步毒性结果

Tumori Journal
IF3.1
2025-12-010
PRE
Carbone, Alessio; Biagioli, Elena; Salutari, Vanda; Lorusso, Domenica; Provinciali, Nicoletta; Bocciolone, Luca; Artioli, Grazia; Abeni, Chiara; Colombo, Nicoletta; De Giorgi, Ugo; Guarneri, Valentina; Cassani, Chiara; Scarfone, Giovanna; Zavallone, Laura; Donadello, Nicoletta; Di Donato, Violante; Giordano, Monica; Scelzi, Elvira; Tognon, Germana; Petrella, Maria Cristina; D'Incalci, Maurizio; Marchini, Sergio; Dang, Hoai Thu; Alvisi, Maria Francesca; Corradengo, Davide; Buttiron Webber, Tania; Paleari, Laura; Briata, Irene Maria; Rutigliani, Mariangela; Oliva, Martino; Rulli, Eliana; DeCensi, Andrea
DOMENICA: dostarlimab versus chemotherapy alone in first-line MMR-deficient advanced endometrial cancer patients

DOMENICA：dostarlimab与单药化疗相比，用于一线治疗MMR缺乏的晚期子宫内膜癌患者

FUTURE ONCOLOGY
IF2.6
2025-05-050
PRE
Cherifi, Francois; Ray-Coquard, Isabelle; Rubio, Maria Jesus; Paoletti, Xavier; Lorusso, Domenica; Choi, Chel Hun; Hasegawa, Kosei; Tan, David Shao Peng; Hudson, Emma; Davis, Alison; Tognon, Germana; Lheureux, Stephanie; Vardar Key, Mehmet Ali; Kurtz, Jean Emmanuel; Alexandre, Jerome; Joly, Florence
Niraparib In Patients With No Residual Disease After Primary Surgery: Preliminary Results Of The MITO 40 Study

尼拉帕利在主要手术后无残留疾病患者中的应用：MITO 40研究的初步结果

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
IF4.7
2025-02-010
PRE
Di Napoli, Marilena; Ferrandina, Gabriella; Scambia, Giovanni; Coppola, Elisabetta; Vertechy, Laura; Cassani, Chiara; Catania, Giovanna; Corsetti, Serena; Abeni, Chiara; Ortega, Cinzia; Ducceschi, Monika; Luvero, Daniela; Petrella, Maria Cristina; Elia, Maria Teresa; Sabbatini, Roberto; Tasca, Giulia; Tognon, Germana; Artioli, Grazia; Zamagn, Claudio; Pignata, Sandro
Unraveling the complexity of HRD assessment in ovarian cancer by combining genomic and functional approaches: translational analyses of MITO16-MaNGO-OV-2 trial
ESMO OPEN
IF8.3
2025-01-011
OAAI
Pellegrino, B.; Capoluongo, E. D.; Bagnoli, M.; Arenare, L.; Califano, D.; Scambia, G.; Cecere, S. C.; Silini, E. M.; Scaglione, G. L.; Spina, A.; Tognon, G.; Campanini, N.; Pisano, C.; Russo, D.; Pettinato, A.; Scollo, P.; Iemmolo, R.; De Cecco, L.; Musolino, A.; Marchini, S.; Beltrame, L.; Paracchini, L.; Perrone, F.; Mezzanzanica, D.; Pignata, S.
TP53 mutations and survival in ovarian carcinoma patients receiving first-line chemotherapy plus bevacizumab: Results of the MITO16A/MaNGO OV-2 study

接受贝伐单抗联合一线化疗的卵巢癌患者的TP53突变和生存率: MITO16A/MaNGO OV-2研究的结果

INTERNATIONAL JOURNAL OF CANCER
IF4.7
2024-10-160
OAAI
Bignotti, Eliana; Simeon, Vittorio; Ardighieri, Laura; Kuhn, Elisabetta; Marchini, Sergio; Califano, Daniela; Cecere, Sabrina Chiara; Bugatti, Mattia; Spina, Anna; Scognamiglio, Giosue; Paracchini, Lara; Russo, Daniela; Arenare, Laura; Tognon, Germana; Lorusso, Domenica; Beltrame, Luca; D'Incalci, Maurizio; Sartori, Enrico; De Censi, Andrea; Odicino, Franco; Perrone, Francesco; Chiodini, Paolo; Pignata, Sandro
Safety and tolerability of durvalumab (D) plus carboplatin/paclitaxel (CP) plus bevacizumab (B) followed by D, B plus olaparib (O) maintenance (mtx) in patients (pts) with newly diagnosed advanced ovarian cancer (AOC) without a tumour BRCA1/BRCA2 mutation (non-tBRCAm) in the phase III DUO-O trial

在DUO-O III期试验中，评估 durvalumab (D) 联合 carboplatin/paclitaxel (CP) 及 bevacizumab (B) 诱导治疗后，再给予 D、B 联合 olaparib (O) 维持治疗（mtx）在无肿瘤 BRCA1/BRCA2 突变（non-tBRCAm）的新诊断晚期卵巢癌（AOC）患者中的安全性与耐受性。

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Aghajanian, C.; Schmalfeldt, B.; Okamoto, A.; Reuss, A.; Kim, J-W.; Ospina, G. Marquina; Ayhan, A.; Salutari, V.; Lebreton, C.; Labudovic, D.; Tognon, G.; Chudecka-Glaz, A. M.; Berger, R.; Lheureux, S.; Henry, S.; Burges, A.; Wenham, R. M.; Nishio, S.; Marshall, L.; Harter, P.
Biological and clinical impact of membrane EGFR expression in a subgroup of OC patients from the phase IV ovarian cancer MITO-16A/MANGO-OV2A trial
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
IF12.8
2023-04-112
OAAI
Forlani, Luca; De Cecco, Loris; Simeon, Vittorio; Paolini, Biagio; Bagnoli, Marina; Cecere, Sabrina Chiara; Spina, Anna; Citeroni, Eleonora; Bignotti, Eliana; Lorusso, Domenica; Arenare, Laura; Russo, Daniela; De Angelis, Carmine; Ardighieri, Laura; Scognamiglio, Giosue; Del Sesto, Michele; Tognon, Germana; Califano, Daniela; Schettino, Clorinda; Chiodini, Paolo; Perrone, Francesco; Mezzanzanica, Delia; Pignata, Sandro; Tomassetti, Antonella
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line
BRITISH JOURNAL OF CANCER
IF6.8
2023-02-0915
OAAI
Colombo, N.; Gadducci, A.; Sehouli, J.; Rulli, E.; Maenpaa, J.; Sessa, C.; Montes, A.; Ottevanger, N. B.; Berger, R.; Vergote, I.; D'Incalci, M.; Galaz, C. Churruca; Chekerov, R.; Nyvang, G. B.; Riniker, S.; Herbertson, R.; Fossati, R.; Barretina-Ginesta, M. P.; Deryal, M.; Mirza, M. R.; Biagioli, E.; Iglesias, M.; Funari, G.; Romeo, M.; Tasca, G.; Pardo, B.; Tognon, G.; Rubio-Perez, M. J.; DeCensi, A.; De Giorgi, U.; Zola, P.; Panici, P. Benedetti; Aglietta, M.; Arcangeli, V.; Zamagni, C.; Bologna, A.; Westermann, A.; Heinzelmann-Schwarz, V.; Tsibulak, I.; Wimberger, P.; Poveda, A.
INOVATYON study: Randomized phase III international study comparing trabectedin/PLD followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line
ANNALS OF ONCOLOGY
IF65.4
2020-09-0118
OAAI
Colombo, N.; Gadducci, A.; Sehouli, J.; Biagioli, E.; Nyvang, G-B.; Riniker, S.; Montes, A.; Ottevanger, N.; Zeimet, A. G. G.; Vergote, I. B.; Funari, G.; Baldoni, A.; Tognon, G.; De Censi, A.; Churruca Galaz, C.; Chekerov, R.; Maenpaa, J.; Rulli, E.; Fossati, R.; Poveda, A.
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer

PRKG1，SDF2L1和PPP1R12A的表达谱是高级别浆液性卵巢癌治疗反应和生存的预测和预后因素

INTERNATIONAL JOURNAL OF CANCER
IF4.7
2020-03-1316
OAAI
Benvenuto, Giuseppe; Todeschini, Paola; Paracchini, Lara; Calura, Enrica; Fruscio, Robert; Romani, Chiara; Beltrame, Luca; Martini, Paolo; Ravaggi, Antonella; Ceppi, Lorenzo; Sales, Gabriele; Donati, Federica; Perego, Patrizia; Zanotti, Laura; Ballabio, Sara; Grassi, Tommaso; Delle Marchette, Martina; Tognon, Germana; Sartori, Enrico; Adorni, Marco; Odicino, Franco; D'Incalci, Maurizio; Bignotti, Eliana; Romualdi, Chiara; Marchini, Sergio
Transcriptional Characterization of Stage I Epithelial Ovarian Cancer: A Multicentric Study
CELLS
IF5.2
2019-12-0111
OAAI
Calura, Enrica; Ciciani, Matteo; Sambugaro, Andrea; Paracchini, Lara; Benvenuto, Giuseppe; Milite, Salvatore; Martini, Paolo; Beltrame, Luca; Zane, Flaminia; Fruscio, Robert; Delle Marchette, Martina; Borella, Fulvio; Tognon, Germana; Ravaggi, Antonella; Katsaros, Dionyssios; Bignotti, Eliana; Odicino, Franco; D'Incalci, Maurizio; Marchini, Sergio; Romualdi, Chiara
Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer

多中心、随机、开放标签、非对照2期临床试验，研究贝伐单抗和曲贝替丁联合或不联合卡铂治疗部分铂类敏感复发性卵巢癌的疗效和安全性

BRITISH JOURNAL OF CANCER
IF6.8
2019-09-2012
OAAI
Colombo, Nicoletta; Zaccarelli, Eleonora; Baldoni, Alessandra; Frezzini, Simona; Scambia, Giovanni; Palluzzi, Eleonora; Tognon, Germana; Lissoni, Andrea A.; Rubino, Daniela; Ferrero, Annamaria; Farina, Gabriella; Negri, Emanuele; Gritti, Angela Pesenti; Galli, Francesca; Biagioli, Elena; Rulli, Eliana; Poli, Davide; Gerardi, Chiara; Torri, Valter; Fossati, Roldano; D'Incalci, Maurizio
ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

Esmo-esgo共识会议关于卵巢癌的建议: 病理学和分子生物学，早期和晚期，交界性肿瘤和复发性疾病

ANNALS OF ONCOLOGY
IF65.4
2019-05-01439
OAAI
Colombo, N.; Sessa, C.; du Bois, A.; Ledermann, J.; McCluggage, W. G.; McNeish, I.; Morice, P.; Pignata, S.; Ray-Coquard, I.; Vergote, I.; Baert, T.; Belaroussi, I.; Dashora, A.; Olbrecht, S.; Planchamp, F.; Querleu, D.; Baert, T.; Banerjee, S.; Belaroussi, I.; Blecharz, P.; Bruchim, I.; Cibula, D.; Colombo, N.; Concin, N.; Davidson, B.; Dashora, A.; Devouassoux-Shisheboran, M.; du Bois, A.; Ferrero, A.; Glasspool, R.; Gonzalez-Martin, A.; Heinzelmann-Schwarz, V.; Joly, F.; Kim, J. W.; Kridelka, F.; Ledermann, J.; Lorusso, D.; Mahner, S.; McCluggage, W. G.; McNeish, I.; Mikami, M.; Mirza, M. R.; Morice, P.; Nicum, S.; Olbrecht, S.; O'Donnell, D. M.; Pautier, P.; Planchamp, F.; Pignata, S.; Querleu, D.; Ray-Coquard, I.; Rodolakis, A.; Sehouli, J.; Selcukbiricik, F.; Sessa, C.; Singh, N.; Tan, D. S. P.; Timmerman, D.; Tognon, G.; van der Velden, J.; Vergote, I.; Witteveen, P. O.; Zeimet, A. G.

研究方向

暂未获取到该数据
E
Eliana Bignotti
H 指数:37论文数:188被引数:4,468
A
Antonella Ravaggi
H 指数:45论文数:220被引数:5,756
L
Laura Zanotti
H 指数:34论文数:178被引数:3,695
F
Franco Odicino
H 指数:50论文数:265被引数:1.1万
C
Chiara Romani
H 指数:30论文数:126被引数:3,143
E
Enrico Sartori
H 指数:53论文数:417被引数:8,212
M
Maurizio D’Incalci
H 指数:80论文数:979被引数:2.4万
E
Elisabetta Bandiera
H 指数:26论文数:107被引数:2,431
S
Sërgio Pecorelli
H 指数:60论文数:251被引数:1.5万
R
Renata Tassi
H 指数:26论文数:117被引数:2,458